Androgen receptor (AR) activation levels on circulating tumor cells (CTCs) to predict response to second-line therapy in castration-resistant prostate cancer (CRPC)

doi:10.1038/scibx.2012.1168

Androgen receptor (AR) activation levels on circulating tumor cells (CTCs) to predict response to second-line therapy in castration-resistant prostate cancer (CRPC)

Science-Business eXchange ◽

10.1038/scibx.2012.1168 ◽

2012 ◽

Vol 5 (44) ◽

pp. 1168-1168

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Second Line ◽

Castration Resistant Prostate Cancer ◽

Second Line Therapy ◽

Castration Resistant ◽

Line Therapy

Download Full-text

MP52-12 COMPARISON OF ALTERNATIVE ANDROGEN RECEPTOR-AXIS-TARGETED AGENT (ARATA) VERSUS DOCETAXEL AS SECOND-LINE THERAPY FOR PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER PROGRESSING AFTER INITIAL ARATA IN REAL-WORLD CLINICAL PRACTICE IN JAPAN

The Journal of Urology ◽

10.1016/j.juro.2018.02.1663 ◽

2018 ◽

Vol 199 (4S) ◽

Author(s):

Yuto Matsushita ◽

Keita Tamura ◽

Takayuki Sugiyama ◽

Hideaki Miyake

Keyword(s):

Prostate Cancer ◽

Clinical Practice ◽

Androgen Receptor ◽

Real World ◽

Second Line ◽

Castration Resistant Prostate Cancer ◽

Second Line Therapy ◽

Castration Resistant ◽

Line Therapy ◽

Targeted Agent

Download Full-text

Comparison of Alternative Androgen Receptor-axis-targeted Agent (ARATA) and Docetaxel as Second-line Therapy for Patients With Metastatic Castration-resistant Prostate Cancer With Progression After Initial ARATA in Real-world Clinical Practice in Japan

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2017.11.007 ◽

2018 ◽

Vol 16 (3) ◽

pp. 219-225 ◽

Cited By ~ 7

Author(s):

Hideaki Miyake ◽

Takayuki Sugiyama ◽

Ryota Aki ◽

Yuto Matsushita ◽

Keita Tamura ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Practice ◽

Androgen Receptor ◽

Real World ◽

Second Line ◽

Castration Resistant Prostate Cancer ◽

Second Line Therapy ◽

Castration Resistant ◽

Line Therapy ◽

Targeted Agent

Download Full-text

Cabazitaxel and prednisone as second-line therapy of metastatic, castration-resistant prostate cancer

Community Oncology ◽

10.1016/s1548-5315(11)70531-9 ◽

2010 ◽

Vol 7 (12) ◽

pp. 540-542 ◽

Cited By ~ 1

Author(s):

Jame Abraham

Keyword(s):

Prostate Cancer ◽

Second Line ◽

Castration Resistant Prostate Cancer ◽

Second Line Therapy ◽

Castration Resistant ◽

Line Therapy

Download Full-text

Second-line therapy in patients with metastatic castration-resistant prostate cancer with progression after or under docetaxel: A systematic review of nine randomized controlled trials

Seminars in Oncology ◽

10.1053/j.seminoncol.2017.10.005 ◽

2017 ◽

Vol 44 (5) ◽

pp. 358-371 ◽

Cited By ~ 7

Author(s):

Michiel H.F. Poorthuis ◽

Robin W.M. Vernooij ◽

R. Jeroen. A. van Moorselaar ◽

Theo M. de Reijke

Keyword(s):

Prostate Cancer ◽

Systematic Review ◽

Randomized Controlled Trials ◽

Controlled Trials ◽

Second Line ◽

Castration Resistant Prostate Cancer ◽

Second Line Therapy ◽

Randomized Controlled ◽

Castration Resistant ◽

Line Therapy

Download Full-text

Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients

Prostate Cancer and Prostatic Diseases ◽

10.1038/s41391-018-0043-z ◽

2018 ◽

Vol 21 (3) ◽

pp. 411-418 ◽

Cited By ~ 12

Author(s):

Manish Kohli ◽

Jian Li ◽

Meijun Du ◽

David W Hillman ◽

Scott M. Dehm ◽

...

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Plasma Cell ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Free Dna ◽

Prognostic Association

Download Full-text

Reply to Julie Steinestel, Christof Bernemann, Andres J. Schrader, and Jochen K. Lennerz's Letter to the Editor re: Emmanuel S. Antonarakis, Changxue Lu, Brandon Luber, et al. Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men with Metastatic Castration-resistant Prostate Cancer Treated with First- and Second-line Abiraterone and Enzalutamide. J Clin Oncol 2017;35:2149–56. AR-V7 Testing: What's in it for the Patient?

European Urology ◽

10.1016/j.eururo.2017.06.032 ◽

2017 ◽

Vol 72 (6) ◽

pp. e170-e171 ◽

Cited By ~ 1

Author(s):

Jun Luo ◽

Brandon Luber ◽

Hao Wang ◽

Emmanuel S. Antonarakis

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Clin Oncol ◽

Tumor Cells ◽

Clinical Significance ◽

Splice Variant ◽

Second Line ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Androgen Receptor Splice Variant

Download Full-text

Apostream to isolate circulating tumor cells (CTC) from castration-resistant prostate cancer patients (CRPC) that express androgen receptor variant 7 (AR-V7) associated with resistance to AR-targeting drugs.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.e23025 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. e23025-e23025

Author(s):

Darren W. Davis ◽

Asifa Haider ◽

Valerie Pierron ◽

Fabien Schmidlin

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

615P Circulating tumor cells (CTC) gene expression and plasma androgen receptor (AR) copy number (CN) in cabazitaxel-treated metastatic castration-resistant prostate cancer (mCRPC)

Annals of Oncology ◽

10.1016/j.annonc.2021.08.1128 ◽

2021 ◽

Vol 32 ◽

pp. S654-S655

Author(s):

G. Gurioli ◽

V. Conteduca ◽

N. Brighi ◽

E. Scarpi ◽

U. Basso ◽

...

Keyword(s):

Gene Expression ◽

Prostate Cancer ◽

Androgen Receptor ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Copy Number ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Abstract 4971: Quantitative image analysis of androgen receptor (AR) and tubulin biomarker profiles in circulating tumor cells (CTCs) from metastatic castration resistant prostate cancer (mCRPC) patients

10.1158/1538-7445.am2016-4971 ◽

2016 ◽

Author(s):

Daniel Worroll ◽

Giuseppe Galletti ◽

David M. Nanus ◽

Scott T. Tagawa ◽

Paraskevi Giannakakou

Keyword(s):

Prostate Cancer ◽

Image Analysis ◽

Androgen Receptor ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Quantitative Image Analysis ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Quantitative Image

Download Full-text

Abstract 2290: Expression pattern of androgen receptor (AR), splice variant 7 (AR-V7) and splice variant 567 (AR-567) in circulating tumor cells and paired plasma-derived exosomes in metastatic castration resistant prostate cancer

10.1158/1538-7445.am2019-2290 ◽

2019 ◽

Author(s):

Areti D. Strati ◽

Martha Zavridou ◽

Evangelos Bournakis ◽

Sophia Mastoraki ◽

Evi S. Lianidou

Keyword(s):

Prostate Cancer ◽

Androgen Receptor ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Expression Pattern ◽

Splice Variant ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text